Activities of AVA LifeScience
Currently, we concentrate on B-cell-associated diseases with a focus on aggressive forms of CLL. We have expanded our scope with projects dealing with other B cell-associated diseases (e.g. diffuse large cell B-cell lymphoma).
Our explicit goal for the future is the development of specific mABs against autoimmune diseases, e.g. Multiple Sclerosis or Rheumatoid Arthritis.